ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMTX Immatics NV

10.51
-0.59 (-5.32%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,062,649
Bid Price 10.50
Ask Price 11.67
News -
Day High 11.2182

Low
5.90

52 Week Range

High
13.16

Day Low 10.455
Company Name Stock Ticker Symbol Market Type
Immatics NV IMTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.59 -5.32% 10.51 17:45:53
Open Price Low Price High Price Close Price Prev Close
11.12 10.455 11.2182 10.51 11.10
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,362 1,062,649 $ 10.92 $ 11,604,335 - 5.90 - 13.16
Last Trade Time Type Quantity Stock Price Currency
16:11:06 priorref 2,513 $ 10.51 USD

Immatics NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
805.8M 76.67M - 172.86M 37.51M 0.49 21.48
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Immatics NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IMTX Message Board. Create One! See More Posts on IMTX Message Board See More Message Board Posts

Historical IMTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.5512.3110.252311.26697,575-0.04-0.38%
1 Month12.5013.1610.252311.85537,529-1.99-15.92%
3 Months10.3013.1610.2111.75536,1520.212.04%
6 Months11.2313.167.1510.48512,217-0.72-6.41%
1 Year7.1513.165.9010.52464,3713.3646.99%
3 Years12.2616.305.7510.45270,643-1.75-14.27%
5 Years17.2519.005.7511.10295,756-6.74-39.07%

Immatics NV Description

Immatics NV is engaged in the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers.

Your Recent History

Delayed Upgrade Clock